Shareholders of Venus Medtech (HKG:2500) will meet Nov. 28 to vote on the proposed sale of certain property and land use rights related to the Qiming Healthcare Life Science Industrial Park in Hangzhou, a Wednesday Hong Kong bourse filing said.
Shares of the medical device maker were down 1% in Thursday afternoon trading.
The 374.6 million yuan deal, signed with Hangzhou Binjiang Urban Construction Development, covers two parcels of land comprising construction in progress and associated land rights.
The parties entered into the agreement on Tuesday, Nov. 11.